The Right Ventricle Still Matters in LVAD Patients Right heart failure signaled trouble ahead in the Intermacs registry Nov 29, 2021
Should Doctors Be Embarrassed by TV's 'Dopesick'? No, but the Hulu series holds lessons for physicians about trusting pharma messaging Nov 26, 2021
Is Psychedelic Research Funding Starting to Shift? Once the province of philanthropy, industry and government sources show interest Nov 24, 2021
Was This Really Our Best Attempt at Step 1 Exam Reform? Shifting to a pass/fail system has unintended consequences Nov 23, 2021
Another Trial, Another PRP Flop in Osteoarthritis Fails to outperform saline in randomized trial Nov 23, 2021
Bisphosphonate Therapy and Fracture Prevention: How Long Does It Take? Meta-analysis determined minimum treatment time needed to see gains Nov 22, 2021
Another Study Confirms Gout Benefit With SGLT2 Inhibitors Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
Let Ethics Guide Aducanumab Prescribing, AAN Says Don't rely on FDA approval alone to make best choices for Alzheimer's patients Nov 18, 2021
Mom's High BP Not a Driver of Offspring's Cardiometabolic Woes in Adulthood Mendelian randomization analysis supports greater role of environmental factors Nov 17, 2021
Jury Still Out on Lithium's Antisuicidal Effects Adjunct lithium offered no additional suicide protection for bipolar, depressed vets Nov 17, 2021
Microstent for Cataract Surgery Reduced Need for Glaucoma Meds Device lowers eye pressure by promoting fluid flow through Schlemm's canal Nov 17, 2021
Need for Liver Transplants Rising Sharply in Seniors Post-transplant mortality still higher versus younger patients, but improving over time Nov 17, 2021
Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
Early Parkinson's Treatment: AAN Issues New Guidelines Levodopa usually is best first therapy for motor symptoms, neurology group says Nov 15, 2021
Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
Aspirin Flops Again for Dementia Prevention ASCEND trial sides with ASPREE, but can't rule out some potential benefit Nov 15, 2021
Stem Cells Don't Prevent Acute Heart Failure Events DREAM-HF trial does hold some positive signals, though Nov 15, 2021
Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementia GIRAF trial tested warfarin versus dabigatran in older Afib patients Nov 14, 2021
AMA Delegates Spar Over Medicare Drug Price Negotiation Some worry this could lead to price controls for physician services Nov 14, 2021
Tricuspid Repair Boosts Mitral Valve Surgery Outcomes Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
Young Physicians Need Support From Organized Medicine, Says AMA President "The fear and weariness ... I'd call it battle fatigue" Nov 13, 2021
Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
Should Medicare Pay the Same Amount Regardless of Where a Service Is Provided? MedPAC members like the idea -- with a few caveats Nov 10, 2021
Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
One Aducanumab Patient, Six Brain Edema Episodes "Uniquely complicated course" for patient treated with new Alzheimer's drug Nov 08, 2021
Early Biologics Better in Juvenile Idiopathic Arthritis After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
Pulmonary Pressure Monitoring Helps HFpEF Too GUIDE-HF substudy supports similar benefits across the ejection fraction spectrum Nov 07, 2021
Is LAA Closure With Amulet Less Leaky? Two studies, IDE and SWISS-APERO, come to disparate conclusions Nov 07, 2021
More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
Investigational Oral CKD-Anemia Agent Effective, Safe HIF-PHI daprodustat increased hemoglobin without hurting heart Nov 05, 2021
LAA Closure Holds Up Against NOACs Longer-term follow-up from the PRAGUE-17 trial reassures Nov 05, 2021
FDA Panel Shows Little Love for Prader-Willi Drug Candidate All but one committee member said phase III evidence for carbetocin nasal spray was insufficient Nov 05, 2021
TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
Diuretic Bolstered Blood Pressure Control in Advanced CKD But some safety signals did arise in 12-week trial Nov 05, 2021
Adenosine-Free Alternative to FFR Bolstered by Longer-Term Data Physiological index boasts good 5-year results in iFR-SWEDEHEART Nov 05, 2021
Focused Ultrasound Approved for Advanced Parkinson's Expanded indication includes medication-refractory PD patients with motor problems Nov 05, 2021
Final Physician Fee Schedule Rule Includes a Nearly 4% Payment Cut Will leave practices in "financial peril," says AMA president Nov 03, 2021
